J Clin Endocrinol Metab 87 : 39974000 Purnell JQ et al
18 Despite the overall consistency in demonstrating the glycemic efficacy of GLP-1 RAs and dual GIP/GLP-1 receptor agonists, substantial heterogeneity exists across studies
As glucose concentration in the bloodstream drops, the decrease in concentrationthe actual negative feedbackis detected by pancreatic cells and insulin release decreases to basal levels
Many patients use GLP-1 therapy to reach a stable weight before undergoing procedures such as liposuction or tummy tuck, enhancing surgical outcomes
Wagoner attended fellowship at CU Anschutz and chose to stay on as faculty, focusing on general endocrinology and medical education
However, both Novo Nordisk and Eli Lilly have downplayed the severity of the gastrointestinal events caused by Ozempic and Mounjaro, never, for example, warning of the risk of gastroparesis or gastroenteritis, the lawsuit states